2 Mg Bortezomib Injection IP

Name: 2 Mg Bortezomib Injection IP
Brand: NEETCO BIOPHARMA
Price: 1000 INR
Availability: InStock

Price 1000 INR/ Vial

Get a Price/Quote

MOQ : 5 Vials

2 Mg Bortezomib Injection IP Specification

Indication
Multiple Myeloma and Mantle Cell Lymphoma

Salt Composition
Bortezomib 2 mg

Dosage Form
Injection

Feature
For Intravenous or Subcutaneous use only

Ingredients
Bortezomib

Application
Oncology/Hematology

Physical Color/Texture
White to off-white lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, protect from light

Shelf Life
24 months

About 2 Mg Bortezomib Injection IP

Select 2 Mg Bortezomib Injection IP, a renowned solution for adults battling Multiple Myeloma and Mantle Cell Lymphoma. Produced in a GMP certified facility, it offers enlightened efficacy and praiseworthy manufacturing standards. Each single-use glass vial contains 2 mg of Bortezomib in a white to off-white lyophilized powder form, ready for IV or SC administration as prescribed by healthcare professionals. Shop now and take advantage of competitive distribution, export, and supply services across India. For hospital and oncology use only, this prescription (Rx) medicine ensures optimal treatment when reconstituted properly. Store below 30C, protected from light.

Specific Usage and Application Guide

2 Mg Bortezomib Injection IP is designed for intravenous or subcutaneous use, strictly under medical supervision. Its primary application is in oncology and hematology, targeting conditions such as Multiple Myeloma and Mantle Cell Lymphoma. The injection is reconstituted with sterile water and administered to adult patients as per a doctor's prescription. Its effective salt composition, Bortezomib 2 mg, ensures both general oncological and specific targeted therapy benefits.

Export Markets, Payment Options, and Certifications

Benefit from the lowest price and flexible asking price when you select this product for your supply needs. 2 Mg Bortezomib Injection IP is widely exported by reputable distributors, exporters, suppliers, and traders throughout India and abroad. Supported by GMP certification, the product meets high quality and safety standards. Payment terms are designed for convenience, ensuring hassle-free and secure transactions for all buyers across the main export markets.

FAQ's of 2 Mg Bortezomib Injection IP:

Q: How should 2 Mg Bortezomib Injection IP be administered?

A: The injection should be administered either intravenously (IV) or subcutaneously (SC) by a healthcare professional following reconstitution with sterile water for injection.

Q: What conditions is the 2 Mg Bortezomib Injection IP indicated for?

A: It is primarily indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma in adult patients.

Q: When should the injection be avoided?

A: This medication is contraindicated in pregnancy and should only be used in hospital and oncology settings as prescribed by a qualified physician.

Q: Where should I store 2 Mg Bortezomib Injection IP to maintain its efficacy?

A: The vial must be stored below 30C and protected from light to ensure product stability. Always check the expiry date before use.

Q: What is the process for reconstituting the injection?

A: Reconstitute the lyophilized powder using sterile water for injection as detailed in the product literature, and administer it immediately under medical supervision for optimal results.

Q: What are the benefits of choosing a GMP certified Bortezomib injection?

A: A GMP certified product assures you of consistent quality, rigorous safety standards, and reliable therapeutic efficacy, benefiting both healthcare providers and patients.

Tell us about your requirement